EICHOR
● Enrolling By Invitation
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
Condition: Acute Myeloid Leukemia · Chronic Myelomonocytic Leukemia · Myelodysplastic Syndromes · Sponsor: Taiho Oncology, Inc.
About this study
Extension study to provide ongoing long-term treatment with ASTX727 for participants who were benefitting from ASTX727 treatment in a previous Taiho (formerly Astex)-sponsored clinical study of ASTX727 (including, but not limited to ASTX727-01 \[NCT02103478\], ASTX727-02 \[NCT03306264\], ASTX727-04 \[NCT03813186\]), ASTX727-06 \[NCT04093570\] food effect substudy, ASTX727-17 \[NCT04953897\], and ASTX727-18 \[NCT04953910\] to obtain long-term safety information. The purpose of the Food Effect Substudy was to evaluate the pharmacokinetics (PK) and safety of decitabine and cedazuridine when ASTX727 was given under fed (high-calorie/high-fat meal or low-calorie/low-fat meal) versus fasted conditions. Food Effect Substudy has now completed.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (47)
| Compassionate Care Research Group | Fountain Valley, California, United States | — |
| Boca Raton Clinical Research | Plantation, Florida, United States | — |
| The University of Chicago Medical Center | Chicago, Illinois, United States | — |
| The Sidney Kimmel Comprehensive Cancer Center at John Hopkins | Baltimore, Maryland, United States | — |
| Cancer and Hematology Centers for Western Michigan | Grand Rapids, Michigan, United States | — |
| Mayo - Rochester | Rochester, Minnesota, United States | — |
| Hackensack Medical Center - 06 FE Study | Hackensack, New Jersey, United States | — |
| Hackensack Medical Center | Hackensack, New Jersey, United States | — |
| Rosewell Park Cancer Institute | Buffalo, New York, United States | — |
| Roswell Park Cancer Institute - 06 FE Study | Buffalo, New York, United States | — |
| Gabrail Cancer Center Research - 06 FE Study | Canton, Ohio, United States | — |
| Gabrail Cancer Center Research | Canton, Ohio, United States | — |
+ 35 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04093570